Tracking RSV Prevention Product Introduction and Use on VIEW-hub

A new module on VIEW-hub, an open-access tool developed by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, collates data on country-level introduction and product use for products to prevent respiratory syncytial virus (RSV), including the maternal vaccine and monoclonal antibodies (mAbs).

Available data include which countries have made mAbs or the maternal vaccine available, either through their national immunization program or the private market, and which countries are planning to do so.

Data are also available on product use, including the timing of maternal vaccination in relation to the RSV transmission season, what mAb products are available, and the target population for mAbs.

For further information: https://view-hub.org/vaccine/rsv

-----

Author: Tory Willens, Research Associate, IVAC (JHU)
Image: RSV product introduction on VIEW-hub